A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density (Q28247445)
Jump to navigation
Jump to search
scientific article (publication date: February 2015)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density |
scientific article (publication date: February 2015) |
Statements
A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density (English)
0 references
February 2015
0 references
30
0 references
2
0 references
216-24
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference